Crossmark

Fezolinetant’s efficacy and safety in treatment of vasomotor symptoms in postmenopausal women: a meta-analysis and GRADE evaluation of randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/s40001-025-02279-y

Published Online: 2025-01-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Allam, Abdallah R. https://orcid.org/0000-0002-4345-2096
Alhateem, Mohamed Salah

Mahmoud, Abdelrahman Mohamed
Funding

Funding for this research was provided by:

The Science, Technology & Innovation Funding Authority
License Information

Text and Data Mining valid from 2025-01-23

Version of Record valid from 2025-01-23
More Information

Article History

Received: 24 December 2023

Accepted: 6 January 2025

First Online: 23 January 2025

Declarations

:

: Not available.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below